Filter Results:
(5,447)
Show Results For
- All HBS Web
(5,447)
- People (18)
- News (2,021)
- Research (2,717)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,991)
Show Results For
- All HBS Web
(5,447)
- People (18)
- News (2,021)
- Research (2,717)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,991)
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- 14 Jun 2021
- News
Why the Hottest Primary Care Startups Aren't Chasing Medicaid
- February 2009 (Revised December 2009)
- Case
Merck: Global Health and Access to Medicines
By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social... View Details
Keywords: Globalized Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Poverty; Business Strategy; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Merck: Global Health and Access to Medicines." Harvard Business School Case 509-048, February 2009. (Revised December 2009.)
- November 2021
- Article
Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-driven Activity-based Costing
By: Tyler R. McClintock, David F. Friedlander, Aiden Y. Feng, Mahek A. Shah, Daniel J. Pallin, Steven L. Chang, Angela M. Bader, Thomas W. Feeley, Robert S. Kaplan and George E. Haleblian
Objective. To characterize full cycle of care costs for managing an acute ureteral stone using time-driven activity-based costing.
Methods. We defined all phases of care for patients presenting with an acute ureteral stone and built an... View Details
Methods. We defined all phases of care for patients presenting with an acute ureteral stone and built an... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Cost; Activity Based Costing and Management
McClintock, Tyler R., David F. Friedlander, Aiden Y. Feng, Mahek A. Shah, Daniel J. Pallin, Steven L. Chang, Angela M. Bader, Thomas W. Feeley, Robert S. Kaplan, and George E. Haleblian. "Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-driven Activity-based Costing." Urology 157 (November 2021): 107–113.
- June 2014 (Revised April 2015)
- Supplement
OrthoChoice: Bundled Payments in the County of Stockholm (B)
By: Michael E. Porter, Clifford M. Marks and Zachary C. Landman
By the end of 2008, all major hospitals (one of which was private) and three private specialized orthopedic centers signed OrthoChoice contracts. In 2009, hip and knee replacements in the County of Stockholm for relatively healthy patients began being reimbursed. By... View Details
Keywords: Hip Replacement; Bundled Payment; Knee Replacement; Value Agenda; Strategy; Health Care Industry; Health; Health Care and Treatment; Health Disorders; Health Industry; Sweden
Porter, Michael E., Clifford M. Marks, and Zachary C. Landman. "OrthoChoice: Bundled Payments in the County of Stockholm (B)." Harvard Business School Supplement 714-515, June 2014. (Revised April 2015.)
- 24 Apr 2014
- News
Student turns family health crisis into online solution
When Shana Hoffman (MBA 2014) and her family tried to navigate the world of health care in the US to help Hoffman’s father with his medical issues, the electrical systems engineer looked at the problem from... View Details
- May 2007 (Revised July 2011)
- Teaching Note
The West German Headache Center: Integrated Migraine Care (TN)
By: Michael E. Porter, Clemens Guth and Elisa M. Dannemiller
Teaching note to 707-559. View Details
- 01 May 2010
- News
The Multi-Stakeholder Movement For Primary Care Renewal And Reform
- June 2013
- Teaching Note
Boston Children's Hospital: Measuring Patient Costs
By: Robert S. Kaplan
- February 1, 2024
- Editorial
Retired Military Officials: Protecting Abortion Care Keeps America Safe
By: Louis Caldera, Ray Mabus and Deborah James
Caldera, Louis, Ray Mabus, and Deborah James. "Retired Military Officials: Protecting Abortion Care Keeps America Safe." Washingtonpost.com (February 1, 2024).
- July 1997
- Article
Market-Driven Health Care: What It Means to You
- 06 Feb 2007
- News
Universal Health Care: A New Business Paradigm?
- 05 Sep 2013
- News
Who Will Radically Disrupt American Health Care?
- March 2014 (Revised December 2014)
- Case
Vision 2020: Takeda and the Vaccine Business
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003... View Details
Keywords: Health Care; Global; NGO; Public Health; Japan; GSK; Vaccine; Supply Chain; Market Entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Case 514-084, March 2014. (Revised December 2014.)
- 06 Sep 2022
- News
Our September Issue: Nurses, Care Delivery, Pharmaceuticals & More
- November 2020 (Revised April 2021)
- Case
Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care
By: Trevor Fetter and Kira Seiger
This case describes the increasing investment by private equity (PE) firms in patient care and other healthcare services. The case focuses on investments in physician staffing firms and roll-up strategy investments in physician practice management (PPM). Included in... View Details
Keywords: Business Ventures; Acquisition; Mergers and Acquisitions; Business Model; Change; Disruption; Fluctuation; Trends; Customers; Customer Value and Value Chain; Ethics; Fairness; Finance; Equity; Insurance; Private Equity; Geography; Geographic Scope; Health; Health Care and Treatment; Markets; Demand and Consumers; Supply and Industry; Industry Structures; Ownership; Ownership Type; Private Ownership; Relationships; Agency Theory; Business and Community Relations; Business and Shareholder Relations; Business and Stakeholder Relations; Networks; Strategy; Competition; Consolidation; Expansion; Integration; Horizontal Integration; Vertical Integration; Value; Value Creation; Health Industry; Health Industry; United States
Fetter, Trevor, and Kira Seiger. "Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care." Harvard Business School Case 321-049, November 2020. (Revised April 2021.)
- 2009
- Book
Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure
A best seller in its category, with many printings. It has been recognized by the U.S. Chamber of Commerce as one of the books that made a difference in public policy in 2008. View Details
Herzlinger, Regina. Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure. McGraw-Hill, 2009.
- 2010
- Working Paper
Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative
By: Nava Ashraf, Gunther Fink and David N. Weil
Since 2003, Zambia has been engaged in a large-scale, centrally coordinated national anti-malaria campaign which has become a model in sub-Saharan Africa. This paper aims at quantifying the individual and macro level benefits of this campaign, which involved mass... View Details
Keywords: Cost vs Benefits; Developing Countries and Economies; Health Care and Treatment; Health Disorders; Performance Evaluation; Programs; Health Industry; Zambia
Ashraf, Nava, Gunther Fink, and David N. Weil. "Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative." NBER Working Paper Series, No. 16069, June 2010.
- April–June 2018
- Article
Establishing Teams: How Does It Change Practice Configuration, Size, and Composition?
By: Alyna Chien, Michael Anne Kyle, Antoinette S. Peters, Shalini Tendulkar, Molly Ryan, Karen Hacker and Sara J. Singer
Little is known about how practices reorganize when transitioning from traditional practice organization to team-based care. We compared practice-level (1) configuration as well as practice- and team-level (2) size and (3) composition, before and after establishing... View Details
Keywords: Academic Medicine; Primary Care; Team-based Care; Health Care and Treatment; Groups and Teams; Organizational Change and Adaptation
Chien, Alyna, Michael Anne Kyle, Antoinette S. Peters, Shalini Tendulkar, Molly Ryan, Karen Hacker, and Sara J. Singer. "Establishing Teams: How Does It Change Practice Configuration, Size, and Composition?" Journal of Ambulatory Care Management 41, no. 2 (April–June 2018): 146–155.